XERS
Xeris Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.95
+6.21%0
Insider buys (3m)
10
Insider sells (3m)
-$1.2M
Net value (3m)
+31.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 2, 2026 | Hecht Beth · officer: See Remarks | Sale | 16,666 | $9.41 |
| Oct 2, 2026 | Pieper Steven · officer: See Remarks | Sale | 5,000 | $9.41 |
| Oct 2, 2026 | McCulloch Kevin · officer: See Remarks | Sale | 15,000 | $9.41 |
| Sep 29, 2026 | McCulloch Kevin · officer: See Remarks | Sale | 25,000 | $10 |
| Sep 1, 2026 | Pieper Steven · officer: See Remarks | Sale | 5,000 | $8.50 |
| Sep 1, 2026 | McCulloch Kevin · officer: See Remarks | Sale | 15,000 | $8.49 |
| Sep 1, 2026 | Hecht Beth · officer: See Remarks | Sale | 16,666 | $8.49 |
| Aug 21, 2026 | McCulloch Kevin · officer: See Remarks | F-InKind | 21,918 | $8.08 |
| Aug 21, 2026 | Shannon John Patrick Jr · director, officer: See Remarks | F-InKind | 36,645 | $8.08 |
| Aug 12, 2026 | Pieper Steven · officer: See Remarks | Sale | 5,000 | $8.50 |
| Aug 4, 2026 | McCulloch Kevin · officer: See Remarks | Sale | 15,000 | $8.02 |
| Aug 4, 2026 | Hecht Beth · officer: See Remarks | Sale | 16,666 | $8.01 |
| Jul 7, 2026 | Pieper Steven · officer: See Remarks | Sale | 17,400 | $8.50 |
| Jul 7, 2026 | Pieper Steven · officer: See Remarks | Sale | 27,600 | $8.52 |
| Jul 2, 2026 | KREHER NERISSA · director | A-Award | 37,910 | $8.00 |
| Jul 2, 2026 | Hecht Beth · officer: See Remarks | Sale | 16,666 | $8.03 |
| Jul 2, 2026 | KREHER NERISSA · director | A-Award | 33,582 | $0.00 |
| Jul 2, 2026 | McCulloch Kevin · officer: See Remarks | Sale | 90,000 | $8.03 |
| Jun 5, 2026 | HALKUFF DAWN · director | Sale | 20,000 | $6.09 |
| Jun 5, 2026 | PERSKY MARLA · director | A-Award | 24,193 | $0.00 |
| Jun 5, 2026 | PERSKY MARLA · director | Sale | 15,500 | $5.90 |
| Jun 5, 2026 | JOHNSON JOHN · director | A-Award | 24,193 | $0.00 |
| Jun 5, 2026 | Kong Garheng · director | A-Award | 32,996 | $6.15 |
| Jun 5, 2026 | HALKUFF DAWN · director | A-Award | 24,193 | $0.00 |
| Jun 5, 2026 | Kong Garheng · director | A-Award | 24,193 | $0.00 |
| Jun 5, 2026 | Brady James Aloysius · director | A-Award | 32,996 | $6.15 |
| Jun 5, 2026 | PERSKY MARLA · director | A-Award | 32,996 | $6.15 |
| Jun 5, 2026 | HALKUFF DAWN · director | A-Award | 32,996 | $6.15 |
| Jun 5, 2026 | JOHNSON JOHN · director | Sale | 15,000 | $6.09 |
| Jun 5, 2026 | BORMANN-KENNEDY BARBARA-JEAN ANNE · director | A-Award | 24,193 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 84Increased 207Reduced 122Sold out 29
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 14,525,539 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 12,945,785 | May 13, 2026 |
| D. E. Shaw & Co., Inc. | Increased | 7,804,758 | Aug 14, 2026 |
| D. E. SHAW & CO., INC. | Increased | 7,788,811 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 7,340,229 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 6,980,882 | May 15, 2026 |
| STATE STREET CORP | Increased | 4,821,566 | Sep 22, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 4,718,183 | Aug 12, 2026 |
| STATE STREET CORP | Increased | 4,658,174 | May 15, 2026 |
| Nuveen, LLC | Increased | 4,385,141 | Aug 11, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 4,290,629 | May 15, 2026 |
| QUBE RESEARCH & TECHNOLOGIES LTD | Increased | 4,114,425 | May 15, 2026 |
| ROSALIND ADVISORS, INC. | Increased | 3,231,700 | May 14, 2026 |
| NUVEEN, LLC | Increased | 2,916,598 | Apr 30, 2026 |
| Rosalind Advisors, Inc. | Reduced | 2,908,981 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 2, 2026